Search research articles
Contact Us
Filters
Showing results (171-180 of 238) with videos related to
Page
of 24
Sort By:
Blood Cells, Molecules & Diseases
|
June 4, 2017
Response to request by journal editorship from Blood Cells, Molecules and Diseases in reference to a "Dear Editor" letter to the Pastores et al. paper, 2016
Gregory M Pastores, Hadhami Ben Turkia, Derlis E Gonzalez, et al.
Blood Cells, Molecules & Diseases
|
August 6, 2010
Preimplantation genetic diagnosis (PGD) for a treatable disorder: Gaucher disease type 1 as a model
Gheona Altarescu, Paul Renbaum, Talia Eldar-Geva, et al.
Blood
|
July 5, 2007
Oral maintenance clinical trial with miglustat for type I Gaucher disease: switch from or combination with intravenous enzyme replacement
Deborah Elstein, Altoon Dweck, Drorit Attias, et al.
International Journal of Molecular Sciences
|
June 26, 2019
Glucosylsphingosine (lyso-Gb1) as a Biomarker for Monitoring Treated and Untreated Children with Gaucher Disease
Noa Hurvitz, Tama Dinur, Michal Becker-Cohen, et al.
American Journal of Hematology
|
April 23, 2016
Enzyme replacement therapy with taliglucerase alfa: 36-month safety and efficacy results in adult patients with Gaucher disease previously treated with imiglucerase
Gregory M Pastores, Suma P Shankar, Milan Petakov, et al.
International Journal of Molecular Sciences
|
May 13, 2026
Glucosylsphingosine (Lyso-Gb1) Dynamics in Untreated States in Gaucher Disease
Tama Dinur, Peter Bauer, Sabine Schroeder, et al.
Molecular Biology International
|
January 16, 2013
Prevention of lysosomal storage diseases and derivation of mutant stem cell lines by preimplantation genetic diagnosis
Gheona Altarescu, Rachel Beeri, Rachel Eiges, et al.
The Journal of Obstetrics and Gynaecology Research
|
March 12, 2014
Outcome of pregnancies in women receiving velaglucerase alfa for Gaucher disease
Deborah Elstein, Derralynn Hughes, Ozlem Goker-Alpan, et al.
Journal of Clinical Medicine
|
May 25, 2024
Long-Term Treatment of Gaucher Disease with Velaglucerase Alfa in ERT-Naïve Patients from the Gaucher Outcome Survey (GOS) Registry
Patrick Deegan, Heather Lau, Deborah Elstein, et al.
Haematologica
|
February 1, 2020
Accuracy of chitotriosidase activity and CCL18 concentration in assessing type I Gaucher disease severity. A systematic review with meta-analysis of individual participant data
Tatiana Raskovalova, Patrick B Deegan, Pramod K Mistry, et al.
Page
of 24
Search research articles
Search
Showing results (171-180 of 238) with videos related to
Sort By:
Page
of 24
Blood Cells, Molecules & Diseases
|
June 4, 2017
Response to request by journal editorship from Blood Cells, Molecules and Diseases in reference to a "Dear Editor" letter to the Pastores et al. paper, 2016
Gregory M Pastores, Hadhami Ben Turkia, Derlis E Gonzalez, et al.
Blood Cells, Molecules & Diseases
|
August 6, 2010
Preimplantation genetic diagnosis (PGD) for a treatable disorder: Gaucher disease type 1 as a model
Gheona Altarescu, Paul Renbaum, Talia Eldar-Geva, et al.
Blood
|
July 5, 2007
Oral maintenance clinical trial with miglustat for type I Gaucher disease: switch from or combination with intravenous enzyme replacement
Deborah Elstein, Altoon Dweck, Drorit Attias, et al.
International Journal of Molecular Sciences
|
June 26, 2019
Glucosylsphingosine (lyso-Gb1) as a Biomarker for Monitoring Treated and Untreated Children with Gaucher Disease
Noa Hurvitz, Tama Dinur, Michal Becker-Cohen, et al.
American Journal of Hematology
|
April 23, 2016
Enzyme replacement therapy with taliglucerase alfa: 36-month safety and efficacy results in adult patients with Gaucher disease previously treated with imiglucerase
Gregory M Pastores, Suma P Shankar, Milan Petakov, et al.
International Journal of Molecular Sciences
|
May 13, 2026
Glucosylsphingosine (Lyso-Gb1) Dynamics in Untreated States in Gaucher Disease
Tama Dinur, Peter Bauer, Sabine Schroeder, et al.
Molecular Biology International
|
January 16, 2013
Prevention of lysosomal storage diseases and derivation of mutant stem cell lines by preimplantation genetic diagnosis
Gheona Altarescu, Rachel Beeri, Rachel Eiges, et al.
The Journal of Obstetrics and Gynaecology Research
|
March 12, 2014
Outcome of pregnancies in women receiving velaglucerase alfa for Gaucher disease
Deborah Elstein, Derralynn Hughes, Ozlem Goker-Alpan, et al.
Journal of Clinical Medicine
|
May 25, 2024
Long-Term Treatment of Gaucher Disease with Velaglucerase Alfa in ERT-Naïve Patients from the Gaucher Outcome Survey (GOS) Registry
Patrick Deegan, Heather Lau, Deborah Elstein, et al.
Haematologica
|
February 1, 2020
Accuracy of chitotriosidase activity and CCL18 concentration in assessing type I Gaucher disease severity. A systematic review with meta-analysis of individual participant data
Tatiana Raskovalova, Patrick B Deegan, Pramod K Mistry, et al.
Page
of 24